Toggle Dropdown
Announcements
Projects
News & Events
Welcome guest
Log in
Loading
Loading...
https://www.ft.com/content/710c1048-7717-4553-a831-9e13ff27fb6c
0
0
Obesity drug maker Novo Nordisk lifts sales forecast - Financial Times
8/10/23 at 8:33am
Organization
Financial Times
Author
Hannah Kuchler
24 words
0
Comments
Danish pharma group is also benefiting from strong US demand for its diabetes treatment
Business & Industrial
Novo Nordisk
Health Conditions
Financial Times
U.S.
You are the first to view
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...